Stocks Technology BKYI
NASDAQ · TechnologyBio Key International Inc (BKYI)
Bio Key International Inc brought in $6.7M of revenue over the twelve months to June 30, 2026, down 3.1% from a year earlier. It posted a net loss of $6M. In fiscal 2025 capital spending exceeded operating cash flow by $4.7M. At June 30, 2026 it held $1.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Bio Key International Inc does
Bio Key International Inc is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NASDAQ under the ticker BKYI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $5.9M | -$7.2M | -$10.77 | -$4.7M |
| 2024 | $6.9M | -$4.3M | -$20.88 | -$2.9M |
| 2023 | $7.8M | -$8.5M | -$151.95 | -$3.8M |
| 2022 | $7M | -$11.9M | -$272.34 | -$6.3M |
| 2021 | $5.1M | -$5.1M | -$6.49 | -$9M |
| 2020 | $2.8M | -$9.7M | -$20.78 | -$5M |
Where BKYI ranks in Technology
Latest SEC filings
What Bio Key International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026Additional proxy material DEFA14A
- September 8, 2026Other event 8-K
- August 24, 2026Additional proxy material DEFA14A
- August 14, 2026Preliminary proxy statement PRE 14A
- August 14, 2026
- August 13, 2026
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 13% to $1.9M versus the same quarter last year; diluted EPS -$0.56 versus -$2.01.
- July 24, 2026
- July 24, 2026Proxy statement DEF 14A
- July 9, 2026Auditor change 8-K
Insider trades
What the people running Bio Key International Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 30, 2026 | Lacous Mira KChief Technology Officer | Received as pay | 250 | $957.5 |
| June 30, 2026 | Depasquale Michael WChief Executive Officer, Director | Received as pay | 250 | $957.5 |
| June 30, 2026 | Sullivan James DavidChief Legal Officer | Received as pay | 250 | $957.5 |
Who owns BKYI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
3 insiders reported holding 24,840 shares in total, about $44.5K at the last price.
| Holder | Shares |
|---|---|
| Depasquale Michael WChief Executive Officer, Director | 10,778 |
| Sullivan James DavidChief Legal Officer | 9,986 |
| Lacous Mira KChief Technology Officer | 4,076 |
Questions about BKYI
What does Bio Key International Inc do?
Bio Key International Inc is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NASDAQ under the ticker BKYI.
Is Bio Key International Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $6M on revenue of $6.7M.
How much revenue does Bio Key International Inc make?
Over the twelve months to June 30, 2026 Bio Key International Inc reported revenue of $6.7M. That is 3.1% less than a year earlier.
When did Bio Key International Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the additional proxy material from September 8, 2026.
Similar companies
Compare BKYI with
Follow BKYI
Get an email when Bio Key International Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow BKYI: get an email when it filesWhere the numbers come from
Financial figures are the values Bio Key International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.